RAC 2.92% $1.94 race oncology ltd

Ann: MD Anderson Preclinical AML Study on Zantrene Published, page-44

  1. 13,155 Posts.
    lightbulb Created with Sketch. 1272
    My point is that the only thing that will arrest the clear technical downtrend is mega results, the usual new trial announcements won't cut it now at this market cap.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.